FDA Investigator

Kaarin M Slotte

Latest inspection on record: Bellingham, United States, June 2026 · records back to 2021

Biologics

FDA inspection record · Last updated August 15, 2026

Overview

  • 98 inspections across 89 sites are on record.
  • 79 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-30.

At a glance

Inspections

98

Sites

89

Observations

79

Career since

May 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Bloodworks30 Jun 2026Biologics
Hamamatsu/Queen's PET Imaging Center, LLC19 May 2026Biologics
Eurofins Donor & Product Testing, Inc.15 May 2026Biologics
Lions World Vision Institute30 Apr 2026Biologics
CorneaGen LLC30 Apr 2026Biologics

Sites inspected

BloodworksBellingham, United States1 insp.
Hamamatsu/Queen's PET Imaging Center, LLCHonolulu, United States1 insp.
Eurofins Donor & Product Testing, Inc.Honolulu, United States1 insp.
Lions World Vision InstituteSeattle, United States1 insp.
CorneaGen LLCSeattle, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Celeta S Coves4 shared
Meihong Liu3 shared

Full investigator report

Get the verbatim findings behind Kaarin M Slotte's 79 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site